Evidence map›Paper›PMID 40733172›Full record

ArticleMolecules (Basel, Switzerland)2025

Towards Understanding the Basis of Brucella Antigen-Antibody Specificity.

Amika Sood, David R Bundle, Robert J Woods

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amika SoodComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602, USA.ORCID 0000-0002-0767-7917
David R BundleDepartment of Chemistry, University of Alberta, Edmonton, AB T6G 2R3, Canada.ORCID 0000-0003-0497-3961
Robert J WoodsComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602, USA.

Funding

Computational tools to aid the design of glycomimetic agentsR01GM135473 · NIGMS · UNIVERSITY OF GEORGIA · PI WOODS, ROBERT J · 2020 to 2024
$1.6M
NIGMS NIH HHS R01 GM135473NIH HHS NIH R01 GM135473
6 · The paper itself

Abstract

Brucellosis continues to be a significant global zoonotic infection, with diagnosis largely relying on the detection of antibodies against the Brucella O-polysaccharide (O-PS) A and M antigens. In this study, computational methods, including homology modeling, molecular docking, and molecular dynamics simulations, were applied to investigate the interaction of the four murine monoclonal antibodies (mAbs) YsT9.1, YsT9.2, Bm10, and Bm28 with hexasaccharide fragments of the A and M epitopes. Through stringent stability criteria, based on interaction energies and mobility of the antigens, high-affinity binding of A antigen with YsT9.1 antibody and M antigen with Bm10 antibody was predicted. In both the complexes hydrophobic interactions dominate the antigen-antibody binding. These findings align well with experimental epitope mapping, indicating YsT9.1's preference for internal sequences of the A epitope and Bm10's preference for internal elements of the M epitope. Interestingly, no stable complexes were identified for YsT9.2 or Bm28 interacting with A or M antigen. This study provides valuable insights into the mechanism of molecular recognition of Brucella O-antigens that can be applied for the development of improved diagnostics, synthetic glycomimetics, and improved vaccine strategies.

Indexed as

Antibodies, BacterialAntibody SpecificityAntigens, BacterialBrucellaO AntigensAnimalsAntibodies, MonoclonalBrucellosisEpitope MappingEpitopesMiceMolecular Docking SimulationMolecular Dynamics SimulationProtein BindingAntibodies, BacterialAntibodies, MonoclonalAntigens, BacterialEpitopesO AntigensAMBERbound complexesBrucella A and M antigensBrucella monoclonal antibodiesGLYCAMhomology modelingMD simulationsMM-GBSA binding energyVina-Carb docking

Identifiers

PMID40733172
PMCPMC12299769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.